There is an emerging and evolving role of SBRT for head and cancer in both de novo and recurrent cases. This presentation will provide an overview of the current evidence supporting the use of SBRT for head and neck cancer, along with insights into its adoption and implementation across Australia. Dr. Ng will also share her institution’s practical considerations and initial experience in establishing a head and neck SBRT program.
